Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Meningioma 7Brain Neoplasms 6Leukemia, Myeloid, Acute 5Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplasms 3Glioblastoma 3Stomach Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Laryngeal Neoplasms 2Gliosarcoma 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Thyroid Carcinoma, Anaplastic 1Thrombocytosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pharyngeal Neoplasms 1Paranasal Sinus Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Nasopharyngeal Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Cisplatin 18Radiotherapy 9Gemcitabine 8Fluorouracil 8Docetaxel 7Paclitaxel 6Carboplatin 5Capecitabine 5Radiotherapy, Intensity-Modulated 4Oxaliplatin 4Nivolumab 3Endostatins 3Bevacizumab 3toripalimab 2spartalizumab 2pembrolizumab 2endostar protein 2apatinib 2Cetuximab 2Celecoxib 2triethanolamine 1sintilimab 1regramostim 1penpulimab 1infigratinib 1fluzoparib 1cc-486 1camrelizumab 1avelumab 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nasopharyngeal Neoplasms × Hydroxyurea × Clear all
NCT00002951 2013-09-05

Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer

University of Chicago

Phase 2 Completed
53 enrolled
GastrointestinalHead & Neck

Esophageal Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡